BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18490300)

  • 1. Fabry's disease presenting as ventricular tachycardia and left ventricular 'hypertrophy'.
    Joshi SB; Ahmar W; Lee G; Aggarwal A
    Eur J Echocardiogr; 2008 Sep; 9(5):697-9. PubMed ID: 18490300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
    Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H
    N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiopulmonary involvement in Fabry's disease.
    Koskenvuo JW; Kantola IM; Nuutila P; Knuuti J; Parkkola R; Mononen I; Hurme S; Kalliokoski R; Viikari JS; Wendelin-Saarenhovi M; Kiviniemi TO; Hartiala JJ
    Acta Cardiol; 2010 Apr; 65(2):185-92. PubMed ID: 20458826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Fabry's disease: an unusual cause of left ventricular hypertrophy.
    Nunes JP; Costa O; Faria Mdo S; Almeida PB; Lacerda L
    Nat Clin Pract Cardiovasc Med; 2007 Nov; 4(11):630-3. PubMed ID: 17957210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease.
    Yoshitama T; Nakao S; Takenaka T; Teraguchi H; Sasaki T; Kodama C; Tanaka A; Kisanuki A; Tei C
    Am J Cardiol; 2001 Jan; 87(1):71-5. PubMed ID: 11137837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac manifestations in Fabry disease].
    Lappegård KT; Aass H
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2395-6. PubMed ID: 11475223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual cause of dyspnea.
    Jamali AH; Ahmed RM; Stein H
    Cardiol Rev; 2004; 12(1):10-4. PubMed ID: 14667257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac magnetic resonance imaging in patients with Fabry's disease.
    Małek LA; Chojnowska L; Spiewak M; Kłopotowski M; Miśko J; Petryka J; Miłosz B; Ruzyłło W
    Kardiol Pol; 2010 Aug; 68(8):929-34. PubMed ID: 20730727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected severe LVH in the elderly: consider Fabry's disease.
    Sorrell VL; Ross WD; Gregoire J; Lai LW; Lien YH
    Echocardiography; 2008 Mar; 25(3):345-8. PubMed ID: 18177384
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myocardial disease in inherited disease].
    Nakao S
    Nihon Rinsho; 2000 Jan; 58(1):200-3. PubMed ID: 10885314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is left ventricular hypertrabeculation/ noncompaction a cardiac manifestation of Fabry's disease?
    Stöllberger C; Finsterer J; Voigtländer T; Slany J
    Z Kardiol; 2003 Nov; 92(11):966-9. PubMed ID: 14634768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Many Faces of Fabry's Cardiomyopathy.
    Jain R; Kalvin L; Johnson B; Muthukumar L; Khandheria BK; Tajik AJ
    JACC Cardiovasc Imaging; 2018 Apr; 11(4):644-647. PubMed ID: 29361493
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.
    Kubo T; Ochi Y; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yoshimitsu M; Higuchi K; Takenaka T; Nakajima K; Togawa T; Tsukimura T; Sano S; Tei C; Sakuraba H; Kitaoka H
    J Cardiol; 2017 Jan; 69(1):302-307. PubMed ID: 27554049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Four cases of Fabry's disease mimicking hypertrophic cardiomyopathy].
    Tanaka H; Adachi K; Yamashita Y; Toshima H; Koga Y
    J Cardiol; 1988 Sep; 18(3):705-18. PubMed ID: 2977798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
    Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
    Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac manifestations of Fabry's disease].
    Han ZH; Jiang TY; Ren XJ; Wu XS; Zhang WD; Chen F
    Zhonghua Nei Ke Za Zhi; 2009 Jun; 48(6):462-4. PubMed ID: 19954039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relief of left ventricular outflow obstruction by cibenzoline in a patient with Fabry's disease--a case report.
    Morimoto S; Sugiura A; Iwase M; Kubo N; Hiramitsu S; Uemura A; Ohtsuki M; Kato S; Kato Y; Hishida H
    Angiology; 2006; 57(2):241-5. PubMed ID: 16518535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tale of two ventricles: unusual causes of left ventricular hypertrophy.
    Pearlamn AS
    Am Heart Hosp J; 2004; 2(4):235-8. PubMed ID: 15538061
    [No Abstract]   [Full Text] [Related]  

  • 19. Fabry disease.
    Yuasa T; Takenaka T; Higuchi K; Uchiyama N; Horizoe Y; Cyaen H; Mizukami N; Takasaki K; Kisanuki A; Miyata M; Ohishi M
    J Echocardiogr; 2017 Dec; 15(4):151-157. PubMed ID: 28674962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiographic and clinical findings in patients with Fabry disease during long-term enzyme replacement therapy: a nationwide Danish cohort study.
    Madsen CV; Bundgaard H; Rasmussen ÅK; Sørensen SS; Petersen JH; Køber L; Feldt-Rasmussen U; Petri H
    Scand Cardiovasc J; 2017 Aug; 51(4):207-216. PubMed ID: 28545342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.